Review



human bc cell lines sw780  (ATCC)


Bioz Verified Symbol ATCC is a verified supplier
Bioz Manufacturer Symbol ATCC manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 96
      Buy from Supplier

    Structured Review

    ATCC human bc cell lines sw780
    Silencing of C19orf10 inhibited the migration and invasion of BC cells. (A-B) The mRNA (A) and protein (B) expression levels of C19orf10 were determined by qPCR and western blot assays, respectively. ** P < 0.01, *** P < 0.001. (C-D) Transwell assays were used to assess the migration and invasion of <t>SW780</t> cells (C) and J82 (D) cells at 48 h after transfection of negative control or C19orf10-specific siRNA oligos. Representative images of cell migration and invasion in the transwell experiments are shown (C-D), and the relative cell motility was quantitated. n = 3 for each group; *** P < 0.001, compared with the control group.
    Human Bc Cell Lines Sw780, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 354 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human bc cell lines sw780/product/ATCC
    Average 96 stars, based on 354 article reviews
    human bc cell lines sw780 - by Bioz Stars, 2026-04
    96/100 stars

    Images

    1) Product Images from "C19orf10 promotes malignant behaviors of human bladder carcinoma cells via regulating the PI3K/AKT and Wnt/β-catenin pathways"

    Article Title: C19orf10 promotes malignant behaviors of human bladder carcinoma cells via regulating the PI3K/AKT and Wnt/β-catenin pathways

    Journal: Journal of Cancer

    doi: 10.7150/jca.56993

    Silencing of C19orf10 inhibited the migration and invasion of BC cells. (A-B) The mRNA (A) and protein (B) expression levels of C19orf10 were determined by qPCR and western blot assays, respectively. ** P < 0.01, *** P < 0.001. (C-D) Transwell assays were used to assess the migration and invasion of SW780 cells (C) and J82 (D) cells at 48 h after transfection of negative control or C19orf10-specific siRNA oligos. Representative images of cell migration and invasion in the transwell experiments are shown (C-D), and the relative cell motility was quantitated. n = 3 for each group; *** P < 0.001, compared with the control group.
    Figure Legend Snippet: Silencing of C19orf10 inhibited the migration and invasion of BC cells. (A-B) The mRNA (A) and protein (B) expression levels of C19orf10 were determined by qPCR and western blot assays, respectively. ** P < 0.01, *** P < 0.001. (C-D) Transwell assays were used to assess the migration and invasion of SW780 cells (C) and J82 (D) cells at 48 h after transfection of negative control or C19orf10-specific siRNA oligos. Representative images of cell migration and invasion in the transwell experiments are shown (C-D), and the relative cell motility was quantitated. n = 3 for each group; *** P < 0.001, compared with the control group.

    Techniques Used: Migration, Expressing, Western Blot, Transfection, Negative Control, Control

    Silencing of C19orf10 inhibited the proliferation and colony formation of BC cells. (A-D) SW780 and J82 cells were transfected with negative control or C19orf10-specific siRNA oligos, and cell proliferation and colony formation were assessed at 48 h after transfection. (A-B) The cell viability after silencing C19orf10 in SW780 (A) and J82 (B) cells was measured using the CCK-8 assay. * P < 0.05, ** P < 0.01, *** P < 0.001. (C)The cell proliferation rates of SW780 cells and J82 cells after silencing C19orf10 were assessed using a colony formation assay, and the number of cell colonies was normalized to that of the negative control group. n = 3 for each group; *** P < 0.001, compared with the control group. (D) Detection of cell proliferation by EdU incorporation assay. The relative proliferation rate was quantitated by calculating the percent of EdU-positive cells. * P < 0.05, *** P < 0.001.
    Figure Legend Snippet: Silencing of C19orf10 inhibited the proliferation and colony formation of BC cells. (A-D) SW780 and J82 cells were transfected with negative control or C19orf10-specific siRNA oligos, and cell proliferation and colony formation were assessed at 48 h after transfection. (A-B) The cell viability after silencing C19orf10 in SW780 (A) and J82 (B) cells was measured using the CCK-8 assay. * P < 0.05, ** P < 0.01, *** P < 0.001. (C)The cell proliferation rates of SW780 cells and J82 cells after silencing C19orf10 were assessed using a colony formation assay, and the number of cell colonies was normalized to that of the negative control group. n = 3 for each group; *** P < 0.001, compared with the control group. (D) Detection of cell proliferation by EdU incorporation assay. The relative proliferation rate was quantitated by calculating the percent of EdU-positive cells. * P < 0.05, *** P < 0.001.

    Techniques Used: Transfection, Negative Control, CCK-8 Assay, Colony Assay, Control

    Deficiency of C19orf10 inhibited the malignant growth of subcutaneous cancer xenografts in vivo . (A) The protein levels of C19orf10 in stable SW780 cells with infection of control or C19orf10-shRNA-expressing lentivirus were determined by western blot assays. (B) The infection efficiency of lentivirus in the above cells was observed under a fluorescence microscope. (C) Growth curves show the tumor sizes in nude mice inoculated with the indicated SW780 cell lines (NC, sh-C19orf10#1, and sh-C19orf10#3 cells) during an observation time of four weeks. n=5 per group; * P < 0.05, ** P < 0.01. (D-E) Mice were sacrificed at 4 weeks after tumor cells inoculation. The images of mice at end-point are shown (D), and the excised tumor tissues were images and weighed (E). * P < 0.05, ** P < 0.01. (F) Representative images of immunohistochemical staining (IHC) analysis of PCNA and Ki67 protein levels in tumor tissues. Scale bars, 100 µm.
    Figure Legend Snippet: Deficiency of C19orf10 inhibited the malignant growth of subcutaneous cancer xenografts in vivo . (A) The protein levels of C19orf10 in stable SW780 cells with infection of control or C19orf10-shRNA-expressing lentivirus were determined by western blot assays. (B) The infection efficiency of lentivirus in the above cells was observed under a fluorescence microscope. (C) Growth curves show the tumor sizes in nude mice inoculated with the indicated SW780 cell lines (NC, sh-C19orf10#1, and sh-C19orf10#3 cells) during an observation time of four weeks. n=5 per group; * P < 0.05, ** P < 0.01. (D-E) Mice were sacrificed at 4 weeks after tumor cells inoculation. The images of mice at end-point are shown (D), and the excised tumor tissues were images and weighed (E). * P < 0.05, ** P < 0.01. (F) Representative images of immunohistochemical staining (IHC) analysis of PCNA and Ki67 protein levels in tumor tissues. Scale bars, 100 µm.

    Techniques Used: In Vivo, Infection, Control, shRNA, Expressing, Western Blot, Fluorescence, Microscopy, Immunohistochemical staining, Staining

    C19orf10 promotes malignant behaviors and EMT of human bladder carcinoma cells via regulating the PI3K/AKT and Wnt/β-catenin pathway. (A) Western blotting analysis of PI3K, p-AKT, total AKT, p21, and p27 expressions in control or C19orf10 siRNA-expressing SW780 and J82 cells. (B) Western blotting analysis of PI3K, p-AKT, AKT (pan), p21, and p27 expressions in control or C19orf10-overexpressed UMUC-3 cells. (C) Western blotting analysis of N-cadherin, Vimentin, Snail, Slug, β-catenin, and p-β-catenin expressions in control or C19orf10 siRNA-expressing SW780 and J82 cells. (D) Western blotting analysis of N-cadherin, Vimentin, Snail, Slug, β-catenin, and p-β-catenin in control or C19orf10-overexpressed UMUC-3 cells.
    Figure Legend Snippet: C19orf10 promotes malignant behaviors and EMT of human bladder carcinoma cells via regulating the PI3K/AKT and Wnt/β-catenin pathway. (A) Western blotting analysis of PI3K, p-AKT, total AKT, p21, and p27 expressions in control or C19orf10 siRNA-expressing SW780 and J82 cells. (B) Western blotting analysis of PI3K, p-AKT, AKT (pan), p21, and p27 expressions in control or C19orf10-overexpressed UMUC-3 cells. (C) Western blotting analysis of N-cadherin, Vimentin, Snail, Slug, β-catenin, and p-β-catenin expressions in control or C19orf10 siRNA-expressing SW780 and J82 cells. (D) Western blotting analysis of N-cadherin, Vimentin, Snail, Slug, β-catenin, and p-β-catenin in control or C19orf10-overexpressed UMUC-3 cells.

    Techniques Used: Western Blot, Control, Expressing



    Similar Products

    human bc cell lines sw780  (ATCC)
    96
    ATCC human bc cell lines sw780
    Silencing of C19orf10 inhibited the migration and invasion of BC cells. (A-B) The mRNA (A) and protein (B) expression levels of C19orf10 were determined by qPCR and western blot assays, respectively. ** P < 0.01, *** P < 0.001. (C-D) Transwell assays were used to assess the migration and invasion of <t>SW780</t> cells (C) and J82 (D) cells at 48 h after transfection of negative control or C19orf10-specific siRNA oligos. Representative images of cell migration and invasion in the transwell experiments are shown (C-D), and the relative cell motility was quantitated. n = 3 for each group; *** P < 0.001, compared with the control group.
    Human Bc Cell Lines Sw780, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human bc cell lines sw780/product/ATCC
    Average 96 stars, based on 1 article reviews
    human bc cell lines sw780 - by Bioz Stars, 2026-04
    96/100 stars
    		  Buy from Supplier
    human bc cells lines (umuc3, tccsup, t24, rt4, sw780, 5637  (iCell Gene Therapeutics)
    90
    iCell Gene Therapeutics human bc cells lines (umuc3, tccsup, t24, rt4, sw780, 5637
    Silencing of C19orf10 inhibited the migration and invasion of BC cells. (A-B) The mRNA (A) and protein (B) expression levels of C19orf10 were determined by qPCR and western blot assays, respectively. ** P < 0.01, *** P < 0.001. (C-D) Transwell assays were used to assess the migration and invasion of <t>SW780</t> cells (C) and J82 (D) cells at 48 h after transfection of negative control or C19orf10-specific siRNA oligos. Representative images of cell migration and invasion in the transwell experiments are shown (C-D), and the relative cell motility was quantitated. n = 3 for each group; *** P < 0.001, compared with the control group.
    Human Bc Cells Lines (Umuc3, Tccsup, T24, Rt4, Sw780, 5637, supplied by iCell Gene Therapeutics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human bc cells lines (umuc3, tccsup, t24, rt4, sw780, 5637/product/iCell Gene Therapeutics
    Average 90 stars, based on 1 article reviews
    human bc cells lines (umuc3, tccsup, t24, rt4, sw780, 5637 - by Bioz Stars, 2026-04
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    Silencing of C19orf10 inhibited the migration and invasion of BC cells. (A-B) The mRNA (A) and protein (B) expression levels of C19orf10 were determined by qPCR and western blot assays, respectively. ** P < 0.01, *** P < 0.001. (C-D) Transwell assays were used to assess the migration and invasion of SW780 cells (C) and J82 (D) cells at 48 h after transfection of negative control or C19orf10-specific siRNA oligos. Representative images of cell migration and invasion in the transwell experiments are shown (C-D), and the relative cell motility was quantitated. n = 3 for each group; *** P < 0.001, compared with the control group.

    Journal: Journal of Cancer

    Article Title: C19orf10 promotes malignant behaviors of human bladder carcinoma cells via regulating the PI3K/AKT and Wnt/β-catenin pathways

    doi: 10.7150/jca.56993

    Figure Lengend Snippet: Silencing of C19orf10 inhibited the migration and invasion of BC cells. (A-B) The mRNA (A) and protein (B) expression levels of C19orf10 were determined by qPCR and western blot assays, respectively. ** P < 0.01, *** P < 0.001. (C-D) Transwell assays were used to assess the migration and invasion of SW780 cells (C) and J82 (D) cells at 48 h after transfection of negative control or C19orf10-specific siRNA oligos. Representative images of cell migration and invasion in the transwell experiments are shown (C-D), and the relative cell motility was quantitated. n = 3 for each group; *** P < 0.001, compared with the control group.

    Article Snippet: The following cell lines were purchased from the American Type Culture Collection (ATCC, Manassas, VA, USA): human BC cell lines SW780 (ATCC® CRL-2169), UMUC3 (ATCC® CRL-1749), 5637 (ATCC® HTB-9), T24 (ATCC® HTB-4), TCCSUP (ATCC® HTB-5TM), and J82 (ATCC® HTB-1), and the immortalized urothelial cell line SV-HUC-1 (ATCC® CRL-9520).

    Techniques: Migration, Expressing, Western Blot, Transfection, Negative Control, Control

    Silencing of C19orf10 inhibited the proliferation and colony formation of BC cells. (A-D) SW780 and J82 cells were transfected with negative control or C19orf10-specific siRNA oligos, and cell proliferation and colony formation were assessed at 48 h after transfection. (A-B) The cell viability after silencing C19orf10 in SW780 (A) and J82 (B) cells was measured using the CCK-8 assay. * P < 0.05, ** P < 0.01, *** P < 0.001. (C)The cell proliferation rates of SW780 cells and J82 cells after silencing C19orf10 were assessed using a colony formation assay, and the number of cell colonies was normalized to that of the negative control group. n = 3 for each group; *** P < 0.001, compared with the control group. (D) Detection of cell proliferation by EdU incorporation assay. The relative proliferation rate was quantitated by calculating the percent of EdU-positive cells. * P < 0.05, *** P < 0.001.

    Journal: Journal of Cancer

    Article Title: C19orf10 promotes malignant behaviors of human bladder carcinoma cells via regulating the PI3K/AKT and Wnt/β-catenin pathways

    doi: 10.7150/jca.56993

    Figure Lengend Snippet: Silencing of C19orf10 inhibited the proliferation and colony formation of BC cells. (A-D) SW780 and J82 cells were transfected with negative control or C19orf10-specific siRNA oligos, and cell proliferation and colony formation were assessed at 48 h after transfection. (A-B) The cell viability after silencing C19orf10 in SW780 (A) and J82 (B) cells was measured using the CCK-8 assay. * P < 0.05, ** P < 0.01, *** P < 0.001. (C)The cell proliferation rates of SW780 cells and J82 cells after silencing C19orf10 were assessed using a colony formation assay, and the number of cell colonies was normalized to that of the negative control group. n = 3 for each group; *** P < 0.001, compared with the control group. (D) Detection of cell proliferation by EdU incorporation assay. The relative proliferation rate was quantitated by calculating the percent of EdU-positive cells. * P < 0.05, *** P < 0.001.

    Article Snippet: The following cell lines were purchased from the American Type Culture Collection (ATCC, Manassas, VA, USA): human BC cell lines SW780 (ATCC® CRL-2169), UMUC3 (ATCC® CRL-1749), 5637 (ATCC® HTB-9), T24 (ATCC® HTB-4), TCCSUP (ATCC® HTB-5TM), and J82 (ATCC® HTB-1), and the immortalized urothelial cell line SV-HUC-1 (ATCC® CRL-9520).

    Techniques: Transfection, Negative Control, CCK-8 Assay, Colony Assay, Control

    Deficiency of C19orf10 inhibited the malignant growth of subcutaneous cancer xenografts in vivo . (A) The protein levels of C19orf10 in stable SW780 cells with infection of control or C19orf10-shRNA-expressing lentivirus were determined by western blot assays. (B) The infection efficiency of lentivirus in the above cells was observed under a fluorescence microscope. (C) Growth curves show the tumor sizes in nude mice inoculated with the indicated SW780 cell lines (NC, sh-C19orf10#1, and sh-C19orf10#3 cells) during an observation time of four weeks. n=5 per group; * P < 0.05, ** P < 0.01. (D-E) Mice were sacrificed at 4 weeks after tumor cells inoculation. The images of mice at end-point are shown (D), and the excised tumor tissues were images and weighed (E). * P < 0.05, ** P < 0.01. (F) Representative images of immunohistochemical staining (IHC) analysis of PCNA and Ki67 protein levels in tumor tissues. Scale bars, 100 µm.

    Journal: Journal of Cancer

    Article Title: C19orf10 promotes malignant behaviors of human bladder carcinoma cells via regulating the PI3K/AKT and Wnt/β-catenin pathways

    doi: 10.7150/jca.56993

    Figure Lengend Snippet: Deficiency of C19orf10 inhibited the malignant growth of subcutaneous cancer xenografts in vivo . (A) The protein levels of C19orf10 in stable SW780 cells with infection of control or C19orf10-shRNA-expressing lentivirus were determined by western blot assays. (B) The infection efficiency of lentivirus in the above cells was observed under a fluorescence microscope. (C) Growth curves show the tumor sizes in nude mice inoculated with the indicated SW780 cell lines (NC, sh-C19orf10#1, and sh-C19orf10#3 cells) during an observation time of four weeks. n=5 per group; * P < 0.05, ** P < 0.01. (D-E) Mice were sacrificed at 4 weeks after tumor cells inoculation. The images of mice at end-point are shown (D), and the excised tumor tissues were images and weighed (E). * P < 0.05, ** P < 0.01. (F) Representative images of immunohistochemical staining (IHC) analysis of PCNA and Ki67 protein levels in tumor tissues. Scale bars, 100 µm.

    Article Snippet: The following cell lines were purchased from the American Type Culture Collection (ATCC, Manassas, VA, USA): human BC cell lines SW780 (ATCC® CRL-2169), UMUC3 (ATCC® CRL-1749), 5637 (ATCC® HTB-9), T24 (ATCC® HTB-4), TCCSUP (ATCC® HTB-5TM), and J82 (ATCC® HTB-1), and the immortalized urothelial cell line SV-HUC-1 (ATCC® CRL-9520).

    Techniques: In Vivo, Infection, Control, shRNA, Expressing, Western Blot, Fluorescence, Microscopy, Immunohistochemical staining, Staining

    C19orf10 promotes malignant behaviors and EMT of human bladder carcinoma cells via regulating the PI3K/AKT and Wnt/β-catenin pathway. (A) Western blotting analysis of PI3K, p-AKT, total AKT, p21, and p27 expressions in control or C19orf10 siRNA-expressing SW780 and J82 cells. (B) Western blotting analysis of PI3K, p-AKT, AKT (pan), p21, and p27 expressions in control or C19orf10-overexpressed UMUC-3 cells. (C) Western blotting analysis of N-cadherin, Vimentin, Snail, Slug, β-catenin, and p-β-catenin expressions in control or C19orf10 siRNA-expressing SW780 and J82 cells. (D) Western blotting analysis of N-cadherin, Vimentin, Snail, Slug, β-catenin, and p-β-catenin in control or C19orf10-overexpressed UMUC-3 cells.

    Journal: Journal of Cancer

    Article Title: C19orf10 promotes malignant behaviors of human bladder carcinoma cells via regulating the PI3K/AKT and Wnt/β-catenin pathways

    doi: 10.7150/jca.56993

    Figure Lengend Snippet: C19orf10 promotes malignant behaviors and EMT of human bladder carcinoma cells via regulating the PI3K/AKT and Wnt/β-catenin pathway. (A) Western blotting analysis of PI3K, p-AKT, total AKT, p21, and p27 expressions in control or C19orf10 siRNA-expressing SW780 and J82 cells. (B) Western blotting analysis of PI3K, p-AKT, AKT (pan), p21, and p27 expressions in control or C19orf10-overexpressed UMUC-3 cells. (C) Western blotting analysis of N-cadherin, Vimentin, Snail, Slug, β-catenin, and p-β-catenin expressions in control or C19orf10 siRNA-expressing SW780 and J82 cells. (D) Western blotting analysis of N-cadherin, Vimentin, Snail, Slug, β-catenin, and p-β-catenin in control or C19orf10-overexpressed UMUC-3 cells.

    Article Snippet: The following cell lines were purchased from the American Type Culture Collection (ATCC, Manassas, VA, USA): human BC cell lines SW780 (ATCC® CRL-2169), UMUC3 (ATCC® CRL-1749), 5637 (ATCC® HTB-9), T24 (ATCC® HTB-4), TCCSUP (ATCC® HTB-5TM), and J82 (ATCC® HTB-1), and the immortalized urothelial cell line SV-HUC-1 (ATCC® CRL-9520).

    Techniques: Western Blot, Control, Expressing